Strata Critical Medical (SRTA) Share-based Compensation (2020 - 2026)

Strata Critical Medical has disclosed Share-based Compensation across 7 years of filings, most recently posting $5.0 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 19.4% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $18.6 million (down 5.77% YoY), while the FY2025 annual figure was $17.8 million, down 10.36% from the prior year.
• Share-based Compensation retreated to $5.0 million in Q1 2026, from $6.6 million in the prior quarter.
• Over the last five years, Share-based Compensation for SRTA reached as high as $6.6 million in Q4 2025 and fell as low as $1.7 million in Q3 2025.
• The 5-year median for Share-based Compensation is $4.2 million (2025), against an average of $4.1 million.
• Annual changes were most pronounced in 2024 — Share-based Compensation jumped 101.89% — and 2025, when it slumped 68.9%.
• A 5-year view of Share-based Compensation shows it stood at $3.9 million in 2022, then dropped by 20.02% to $3.2 million in 2023, then surged by 43.55% to $4.5 million in 2024, then soared by 45.51% to $6.6 million in 2025, then dropped by 23.55% to $5.0 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $5.0 million, $6.6 million, and $1.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.